急性ST段抬高型心肌梗死临床路径实施变异分析

Analysis of Variations in the Implementation of the Clinical Pathways for Acute ST Elevation in Myocardial Infarction

45例急性ST段抬高心肌梗死(STEMI)患者,按照卫生部颁布的临床路径进行处理和治疗,分析实施过程中的各种变异。结果发现,实施过程中的变异主要是来自患者方面的变异,部分变异来自医院系统,医护人员方面的变异相对较少。这些变异多为负性变异,部分为可控性变异。据此采取针对性变异控制策略,减少临床路径实施过程中的变异,以提高医疗服务质量。

According to the standardized clinical pathway published by China＇s Ministry of Health,45 cases of acute ST Elevation of myocardial infarction （STEMI） were treated in the author＇s hospital. The variations in the implementation of the clinic pathways were analyzed and it is found that the variations mainly came from the patients while some variations were caused by the hospital system. In comparison,fewer variations were due to the staff. Most variations were negative,and some were controllable. Based on the findings,control strategies were taken and variations decreased,so the quality of medical services improved.